Spots Global Cancer Trial Database for bevacizumab [avastin]
Every month we try and update this database with for bevacizumab [avastin] cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
| Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
|---|---|---|---|---|---|---|
| A Study of Avastin (Bevacizumab) + Xeloda (Capecitabine)as Maintenance Therapy in Patients With HER2-Negative Metastatic Breast Cancer | NCT00929240 | Breast Cancer | bevacizumab [Av... capecitabine [X... | 18 Years - | Hoffmann-La Roche | |
| A Study of Xeloda (Capecitabine) in Combination With Avastin + Short Course Chemotherapy in Patients With Metastatic Colorectal Cancer | NCT00642603 | Colorectal Canc... | capecitabine [X... capecitabine [X... bevacizumab [Av... oxaliplatin irinotecan | 18 Years - | Hoffmann-La Roche | |
| A Study of Avastin (Bevacizumab) And Fotemustine in Patients With Recurrent Glioblastoma | NCT01474239 | Glioblastoma Mu... | bevacizumab [Av... fotemustine | 18 Years - | Hoffmann-La Roche | |
| A Study of Avastin (Bevacizumab) in Combination With Gemcitabine With or Without Cisplatin in First-Line Treatment of Elderly Patients With Non-Small Cell Lung Cancer | NCT01077713 | Non-Squamous No... | bevacizumab [Av... cisplatin gemcitabine gemcitabine | 70 Years - | Hoffmann-La Roche | |
| A Study of Avastin (Bevacizumab) in Combination With Herceptin (Trastuzumab) and Xeloda (Capecitabine) in Patients With HER2-Positive Breast Cancer | NCT00811135 | Breast Cancer | bevacizumab [Av... capecitabine [X... trastuzumab [He... | 18 Years - | Hoffmann-La Roche | |
| A Study of Avastin (Bevacizumab) in Combination Chemotherapy in Patients With Metastatic Cancer of the Colon or Rectum | NCT01131078 | Colorectal Canc... | Bevacizumab [Av... Capecitabine Irinotecan | 18 Years - | Hoffmann-La Roche | |
| A Study of The Safety Profile of First-line Avastin (Bevacizumab) in Combination With Paclitaxel in Patients With Locally Recurrent or Metastatic Her2-negative Breast Cancer (AVATAX) | NCT01156961 | Breast Cancer | bevacizumab [Av... paclitaxel | 18 Years - | Hoffmann-La Roche | |
| A Study of Avastin (Bevacizumab) in Combination With Carboplatin-Based Chemotherapy in Patients With Advanced or Recurrent Non-Squamous Non-Small Cell Lung Cancer. | NCT00700180 | Non-Small Cell ... | bevacizumab [Av... bevacizumab [Av... Carboplatin-bas... | 18 Years - | Hoffmann-La Roche | |
| A Genetic Substudy Associated With the Avastin (Bevacizumab) Study MO19390 in Patients With Advanced or Recurrent Non-Squamous Cell Lung Cancer. | NCT00642824 | Non-Squamous No... | Standard chemot... bevacizumab [Av... | 18 Years - | Hoffmann-La Roche | |
| A Study of Avastin (Bevacizumab) in Combination With Xeloda (Capecitabine) and Docetaxel in Patients With Inflammatory or Locally Advanced Breast Cancer. | NCT00576901 | Breast Cancer | bevacizumab [Av... Docetaxel Xeloda | 18 Years - | Hoffmann-La Roche | |
| AVAPERL1 Study: A Study of Avastin (Bevacizumab) With or Without Pemetrexed as Maintenance Therapy After Avastin in First Line in Patients With Non-Squamous Non-Small Cell Lung Cancer | NCT00961415 | Non-Squamous No... | bevacizumab [Av... cisplatin pemetrexed | 18 Years - | Hoffmann-La Roche | |
| A Study of Avastin (Bevacizumab) in Combination With Chemotherapy in Patients With Endocrine Tumors of the Gastrointestinal Tract. | NCT00448136 | Neoplasms | bevacizumab [Av... 5 FU Streptozotocin Xeloda | 18 Years - | Hoffmann-La Roche | |
| A Study of Avastin (Bevacizumab) in Combination With Standard Chemotherapy in Children and Adolescents With Sarcoma. | NCT00643565 | Sarcoma | Standard chemot... bevacizumab [Av... | 6 Months - 18 Years | Hoffmann-La Roche | |
| A Study of Avastin (Bevacizumab) in Combination With Fotemustine in Patients With Metastatic Melanoma | NCT01069627 | Malignant Melan... | bevacizumab [Av... fotemustine | 18 Years - | Hoffmann-La Roche | |
| A Study of Avastin (Bevacizumab) in Patients With Non-Squamous Non-Small Cell Lung Cancer (NSCLC) | NCT00806923 | Non-Squamous No... | Cisplatin Gemcitabine Placebo bevacizumab [Av... bevacizumab [Av... | 18 Years - | Hoffmann-La Roche | |
| A Study of Avastin (Bevacizumab) Added to Interferon Alfa-2a (Roferon) Therapy in Patients With Metastatic Renal Cell Cancer With Nephrectomy | NCT00738530 | Renal Cell Canc... | Bevacizumab [Av... Interferon alfa... Placebo | 18 Years - | Hoffmann-La Roche | |
| A Study of Avastin (Bevacizumab) in Combination With Platinum-Containing Chemotherapy in Patients With Advanced or Recurrent Non-Squamous Cell Lung Cancer. | NCT00451906 | Non-Squamous No... | Platinum-based ... Bevacizumab [Av... | 18 Years - | Hoffmann-La Roche | |
| A Study of Avastin (Bevacizumab) And Fotemustine in Patients With Recurrent Glioblastoma | NCT01474239 | Glioblastoma Mu... | bevacizumab [Av... fotemustine | 18 Years - | Hoffmann-La Roche | |
| A Study of Avastin (Bevacizumab) in Combination With Herceptin (Trastuzumab)/Docetaxel in Patients With HER2 Positive Metastatic Breast Cancer. | NCT00391092 | Breast Cancer | bevacizumab [Av... Docetaxel Herceptin | 18 Years - | Hoffmann-La Roche | |
| A Study of Avastin (Bevacizumab) in Combination With Platinum-Based Chemotherapy in Patients With Advanced or Recurrent Squamous Non-Small Cell Lung Cancer | NCT00404703 | Non-Small Cell ... | bevacizumab [Av... Platinum-based ... | 18 Years - | Hoffmann-La Roche | |
| A Feasibility Trial of Avastin (Bevacizumab) in Combination With Concomitant Chemoradiation (Cisplatin and Vinorelbine) in Patients With Locally Advanced Non-Squamous Non-Small Cell Lung Cancer. | NCT00773188 | Non-Squamous No... | bevacizumab [Av... cisplatin vinorelbine | 18 Years - | Hoffmann-La Roche | |
| A Study of Circulating Endothelial Cell as Marker for Avastin (Bevacizumab) in Combination With Docetaxel Plus Xeloda (Capecitabine) as First Line Treatment for Patients With Locally Recurrent and Metastatic Breast Cancer | NCT00845910 | Breast Cancer | bevacizumab [Av... capecitabine [X... docetaxel | 18 Years - 65 Years | Hoffmann-La Roche | |
| FOLFOX/Bevacizumab With Onartuzumab (MetMAb) Versus Placebo as First-Line Treatment in Patients With Metastatic Colorectal Cancer | NCT01418222 | Colorectal Canc... | 5-FU FOLFOX regimen Placebo bevacizumab [Av... leucovorin onartuzumab [Me... | 18 Years - | Genentech, Inc. | |
| A Study of Avastin (Bevacizumab) in Combination With Standard Therapy in Patients With Metastatic Renal Cell Cancer. | NCT00520403 | Renal Cell Canc... | bevacizumab [Av... Interferon alfa... Vinblastine | 18 Years - | Hoffmann-La Roche | |
| A Study of Avastin (Bevacizumab) in Combination With Low-Dose-Interferon in Patients With Metastatic Clear Cell Renal Cell Carcinoma (RCC). | NCT00796757 | Renal Cell Canc... | bevacizumab [Av... interferon alfa... | 18 Years - | Hoffmann-La Roche | |
| OPAL Study: A Study of Avastin (Bevacizumab) in Combination With FOLFOXIRI in Patients With Previously Untreated Metastatic Colorectal Cancer | NCT00940303 | Colorectal Canc... | 5-FU bevacizumab [Av... irinotecan leucovorin oxaliplatin | 18 Years - 70 Years | Hoffmann-La Roche | |
| A Study of Avastin (Bevacizumab) With XELOX or FOLFOX in Patients With Metastatic Colorectal Cancer and Disease Progression Under First-line FOLFIRI and Avastin | NCT01077739 | Colorectal Canc... | fluorouracil (5... leucovorin bevacizumab [Av... capecitabine [X... oxaliplatin | 18 Years - | Hoffmann-La Roche | |
| AVAPERL1 Study: A Study of Avastin (Bevacizumab) With or Without Pemetrexed as Maintenance Therapy After Avastin in First Line in Patients With Non-Squamous Non-Small Cell Lung Cancer | NCT00961415 | Non-Squamous No... | bevacizumab [Av... cisplatin pemetrexed | 18 Years - | Hoffmann-La Roche | |
| PRIMADOS Study:A Study of Avastin (Bevacizumab) Plus Docetaxel for First Line Treatment of Patients With Metastatic Breast Cancer | NCT00774241 | Breast Cancer | bevacizumab [Av... docetaxel | 18 Years - | Hoffmann-La Roche | |
| A Study of Avastin (Bevacizumab) in Combination With Xelox and Tarceva in Patients With Metastatic Colorectal Cancer. | NCT01135498 | Colorectal Canc... | bevacizumab [Av... eloxatin capecitabine [X... erlotinib [Tarc... | 18 Years - | Hoffmann-La Roche | |
| Observational Study of Bevacizumab [Avastin] in Patients With Metastatic Colorectal Cancer (AVASTART) | NCT01089413 | Colorectal Canc... | bevacizumab [Av... | 18 Years - | Hoffmann-La Roche | |
| A Study of Avastin (Bevacizumab) With XELOX or FOLFOX in Patients With Metastatic Colorectal Cancer and Disease Progression Under First-line FOLFIRI and Avastin | NCT01077739 | Colorectal Canc... | fluorouracil (5... leucovorin bevacizumab [Av... capecitabine [X... oxaliplatin | 18 Years - | Hoffmann-La Roche | |
| A Study of Avastin (Bevacizumab) and Xeloda (Capecitabine) in Patients With Advanced or Metastatic Liver Cancer | NCT02013830 | Liver Cancer | bevacizumab [Av... capecitabine [X... | 18 Years - | Hoffmann-La Roche | |
| A Study of Avastin (Bevacizumab) and Irinotecan Versus Temozolomide Radiochemistry in Patients With Glioblastoma | NCT00967330 | Glioblastoma Mu... | bevacizumab [Av... irinotecan temozolomide | 18 Years - 70 Years | Hoffmann-La Roche | |
| A Study of Avastin (Bevacizumab) Added to a Chemotherapeutic Regimen in Patients With Metastatic Pancreatic Cancer | NCT01214720 | Pancreatic Canc... | bevacizumab [Av... | 18 Years - | Hoffmann-La Roche | |
| A Study of Avastin (Bevacizumab) in Combination With Thoracic Radiation and Chemotherapy in Patients With Advanced Non-Squamous Non-Small Cell Lung Cancer. | NCT00776698 | Non-Squamous No... | bevacizumab [Av... cisplatin etoposide | 18 Years - | Hoffmann-La Roche | |
| OBELIX Study: A Study of Avastin (Bevacizumab) in Combination With XELOX in Patients With Metastatic Cancer of the Colon or Rectum. | NCT00577031 | Colorectal Canc... | bevacizumab [Av... Oxaliplatin Xeloda | 18 Years - | Hoffmann-La Roche | |
| A Study of Avastin (Bevacizumab) And Fotemustine in Patients With Recurrent Glioblastoma | NCT01474239 | Glioblastoma Mu... | bevacizumab [Av... fotemustine | 18 Years - | Hoffmann-La Roche | |
| A Study of Avastin (Bevacizumab) and Sequential Chemotherapy in Patients With Primary HER2 Negative Operable Breast Cancer. | NCT00559754 | Breast Cancer | bevacizumab [Av... Docetaxel Standard chemot... | 18 Years - | Hoffmann-La Roche | |
| A Study of Xeloda (Capecitabine) in Combination With Avastin + Short Course Chemotherapy in Patients With Metastatic Colorectal Cancer | NCT00642603 | Colorectal Canc... | capecitabine [X... capecitabine [X... bevacizumab [Av... oxaliplatin irinotecan | 18 Years - | Hoffmann-La Roche | |
| A Study of Avastin (Bevacizumab) in Combination With Herceptin (Trastuzumab) and Xeloda (Capecitabine) in Patients With HER2-Positive Breast Cancer | NCT00811135 | Breast Cancer | bevacizumab [Av... capecitabine [X... trastuzumab [He... | 18 Years - | Hoffmann-La Roche | |
| A Study of Avastin (Bevacizumab) in Combination With Platinum-Based Chemotherapy in Patients With Advanced or Recurrent Squamous Non-Small Cell Lung Cancer | NCT00404703 | Non-Small Cell ... | bevacizumab [Av... Platinum-based ... | 18 Years - | Hoffmann-La Roche | |
| A Study of Avastin (Bevacizumab) in Patients With Non-Squamous Non-Small Cell Lung Cancer With Asymptomatic Untreated Brain Metastasis | NCT00800202 | Non-Small Cell ... | bevacizumab [Av... carboplatin erlotinib [Tarc... paclitaxel | 18 Years - | Hoffmann-La Roche | |
| A Study of Avastin (Bevacizumab) Combined With Chemotherapy in Patients With Metastatic Cancer of the Colon or Rectum | NCT01181609 | Colorectal Canc... | bevacizumab [Av... | 18 Years - | Hoffmann-La Roche | |
| FOLFOX/Bevacizumab With Onartuzumab (MetMAb) Versus Placebo as First-Line Treatment in Patients With Metastatic Colorectal Cancer | NCT01418222 | Colorectal Canc... | 5-FU FOLFOX regimen Placebo bevacizumab [Av... leucovorin onartuzumab [Me... | 18 Years - | Genentech, Inc. | |
| A Study of Herceptin (Trastuzumab) in Combination With Avastin (Bevacizumab) and Sequential Xeloda (Capecitabine) or Docetaxel in Patients With HER2-Positive Locally Recurrent or Metastatic Breast Cancer | NCT00964704 | Breast Cancer | bevacizumab [Av... capecitabine [X... docetaxel trastuzumab [He... | 18 Years - | Hoffmann-La Roche | |
| A Study of Herceptin (Trastuzumab) in Combination With Avastin (Bevacizumab) and Sequential Xeloda (Capecitabine) or Docetaxel in Patients With HER2-Positive Locally Recurrent or Metastatic Breast Cancer | NCT00964704 | Breast Cancer | bevacizumab [Av... capecitabine [X... docetaxel trastuzumab [He... | 18 Years - | Hoffmann-La Roche | |
| A Study of Avastin (Bevacizumab) in Combination With Chemotherapy in Patients With Primary Breast Cancer | NCT02005549 | Breast Cancer | bevacizumab [Av... docetaxel capecitabine [X... | 18 Years - 70 Years | Hoffmann-La Roche | |
| A Study of Avastin (Bevacizumab) + Xeloda (Capecitabine)as Maintenance Therapy in Patients With HER2-Negative Metastatic Breast Cancer | NCT00929240 | Breast Cancer | bevacizumab [Av... capecitabine [X... | 18 Years - | Hoffmann-La Roche | |
| A Study of Avastin (Bevacizumab) in Combination With Chemotherapy in Patients With Primary Breast Cancer | NCT02005549 | Breast Cancer | bevacizumab [Av... docetaxel capecitabine [X... | 18 Years - 70 Years | Hoffmann-La Roche | |
| A Study of Avastin (Bevacizumab) Plus Herceptin (Trastuzumab) in Patients With Primary Inflammatory HER2-Positive Breast Cancer. | NCT00717405 | Breast Cancer | Standard chemot... bevacizumab [Av... trastuzumab [He... | 18 Years - | Hoffmann-La Roche | |
| A Study of Avastin (Bevacizumab) in Combination With Standard Therapy in Patients With Metastatic Renal Cell Cancer. | NCT00520403 | Renal Cell Canc... | bevacizumab [Av... Interferon alfa... Vinblastine | 18 Years - | Hoffmann-La Roche | |
| ATX Study:A Study of Avastin (Bevacizumab), Tarceva (Erlotinib) and Xeloda (Capecitabine) in Patients With Locally Advanced and/or Metastatic Pancreatic Cancer | NCT00925769 | Pancreatic Canc... | bevacizumab [Av... capecitabine [X... erlotinib [Tarc... | 18 Years - | Hoffmann-La Roche | |
| A Study of Avastin (Bevacizumab) in Combination With Chemotherapy in Patients With Previously Untreated Metastatic Colorectal Cancer. | NCT00577109 | Colorectal Canc... | bevacizumab [Av... Irinotecan Leucovorin 5 FU Cetuximab | 18 Years - | Hoffmann-La Roche | |
| A Study of Avastin (Bevacizumab) in Combination With mFOLFOX6 in Treatment-Naïve Patients With Metastatic Colorectal Cancer With or Without K-RAS Mutations, and Comparison to Cetuximab | NCT01338558 | Colorectal Canc... | bevacizumab [Av... cetuximab mFOLFOX6 | 18 Years - | Hoffmann-La Roche | |
| A Study of Avastin (Bevacizumab) in Combination With Chemotherapy in Chinese Patients With Metastatic Colorectal Cancer. | NCT00642577 | Colorectal Canc... | bevacizumab [Av... irinotecan leucovorin fluorouracil | 18 Years - | Hoffmann-La Roche | |
| A Study of Avastin (Bevacizumab) in Combination With mFOLFOX-6 or FOLFOXIRI in Patients With Metastatic Colorectal Cancer. | NCT00778102 | Colorectal Canc... | 5-FU 5-FU 5-FU Irinotecan Leucovorin Leucovorin Oxaliplatin bevacizumab [Av... | 18 Years - | Hoffmann-La Roche | |
| OPAL Study: A Study of Avastin (Bevacizumab) in Combination With FOLFOXIRI in Patients With Previously Untreated Metastatic Colorectal Cancer | NCT00940303 | Colorectal Canc... | 5-FU bevacizumab [Av... irinotecan leucovorin oxaliplatin | 18 Years - 70 Years | Hoffmann-La Roche | |
| A Study of Avastin (Bevacizumab) in Combination With Carboplatin-Based Chemotherapy in Patients With Advanced or Recurrent Non-Squamous Non-Small Cell Lung Cancer. | NCT00700180 | Non-Small Cell ... | bevacizumab [Av... bevacizumab [Av... Carboplatin-bas... | 18 Years - | Hoffmann-La Roche | |
| A Study of Herceptin (Trastuzumab) in Combination With Avastin (Bevacizumab) and Sequential Xeloda (Capecitabine) or Docetaxel in Patients With HER2-Positive Locally Recurrent or Metastatic Breast Cancer | NCT00964704 | Breast Cancer | bevacizumab [Av... capecitabine [X... docetaxel trastuzumab [He... | 18 Years - | Hoffmann-La Roche | |
| A Study of Avastin (Bevacizumab) in Combination With Low-Dose-Interferon in Patients With Metastatic Clear Cell Renal Cell Carcinoma (RCC). | NCT00796757 | Renal Cell Canc... | bevacizumab [Av... interferon alfa... | 18 Years - | Hoffmann-La Roche | |
| A Study of Avastin (Bevacizumab) With XELOX or FOLFOX in Patients With Metastatic Colorectal Cancer and Disease Progression Under First-line FOLFIRI and Avastin | NCT01077739 | Colorectal Canc... | fluorouracil (5... leucovorin bevacizumab [Av... capecitabine [X... oxaliplatin | 18 Years - | Hoffmann-La Roche | |
| A Study of R1507 in Combination With Multiple Standard Chemotherapy Treatments in Patients With Advanced Solid Tumors | NCT00811993 | Neoplasms | RG1507 RO1507 bevacizumab [Av... capecitabine [X... carboplatin cetuximab docetaxel erlotinib [Tarc... etoposide gemcitabine irinotecan mFOLFOX6 paclitaxel pemetrexel sorafenib temozolomide trastuzumab [He... | 18 Years - | Hoffmann-La Roche | |
| Study To Evaluate the Efficacy and Safety Of Bevacizumab, and Associated Biomarkers, In Combination With Paclitaxel Compared With Paclitaxel Plus Placebo as First-line Treatment Of Patients With Her2-Negative Metastatic Breast Cancer | NCT01663727 | Metastatic Brea... | Bevacizumab [Av... Paclitaxel Placebo | 18 Years - | Hoffmann-La Roche | |
| A Study of Avastin (Bevacizumab) in Combination With XELOX or FOLFOX-4 in Patients With Metastatic Colorectal Cancer. | NCT00349336 | Colorectal Canc... | bevacizumab [Av... XELOX bevacizumab [Av... FOLFOX-4 | 18 Years - | Hoffmann-La Roche | |
| A Study of Avastin (Bevacizumab) Plus Herceptin (Trastuzumab) in Patients With Primary Inflammatory HER2-Positive Breast Cancer. | NCT00717405 | Breast Cancer | Standard chemot... bevacizumab [Av... trastuzumab [He... | 18 Years - | Hoffmann-La Roche | |
| A Study of Herceptin (Trastuzumab) in Combination With Avastin (Bevacizumab) and Sequential Xeloda (Capecitabine) or Docetaxel in Patients With HER2-Positive Locally Recurrent or Metastatic Breast Cancer | NCT00964704 | Breast Cancer | bevacizumab [Av... capecitabine [X... docetaxel trastuzumab [He... | 18 Years - | Hoffmann-La Roche | |
| A Study of Avastin (Bevacizumab) in Combination With XELOX or FOLFOX-4 in Patients With Metastatic Colorectal Cancer. | NCT00349336 | Colorectal Canc... | bevacizumab [Av... XELOX bevacizumab [Av... FOLFOX-4 | 18 Years - | Hoffmann-La Roche | |
| A Study of Avastin (Bevacizumab) in Combination With mFOLFOX6 in Treatment-Naïve Patients With Metastatic Colorectal Cancer With or Without K-RAS Mutations, and Comparison to Cetuximab | NCT01338558 | Colorectal Canc... | bevacizumab [Av... cetuximab mFOLFOX6 | 18 Years - | Hoffmann-La Roche | |
| A Study of Avastin (Bevacizumab) in Combination With Chemotherapy in Patients With Breast Cancer Progressing After First-Line Therapy With Avastin and Chemotherapy (TANIA) | NCT01250379 | Breast Cancer | bevacizumab [Av... Chemotherapy | 18 Years - | Hoffmann-La Roche | |
| A Study of Avastin (Bevacizumab) in Combination With Chemotherapy in Patients With Breast Cancer Progressing After First-Line Therapy With Avastin and Chemotherapy (TANIA) | NCT01250379 | Breast Cancer | bevacizumab [Av... Chemotherapy | 18 Years - | Hoffmann-La Roche | |
| A Study of Avastin (Bevacizumab) in Combination With Xelox and Tarceva in Patients With Metastatic Colorectal Cancer. | NCT01135498 | Colorectal Canc... | bevacizumab [Av... eloxatin capecitabine [X... erlotinib [Tarc... | 18 Years - | Hoffmann-La Roche | |
| A Study of Avastin (Bevacizumab) and Oxaliplatin Plus Xeloda (Capecitabine) in Patients With Advanced Colorectal Cancer. | NCT01159171 | Colorectal Canc... | bevacizumab [Av... capecitabine [X... oxaliplatin | 18 Years - | Hoffmann-La Roche | |
| A Study of Avastin (Bevacizumab) Added to Interferon Alfa-2a (Roferon) Therapy in Patients With Metastatic Renal Cell Cancer With Nephrectomy | NCT00738530 | Renal Cell Canc... | Bevacizumab [Av... Interferon alfa... Placebo | 18 Years - | Hoffmann-La Roche | |
| A Study of Avastin (Bevacizumab) Plus Taxane-Based Therapy in Patients With Locally Recurrent or Metastatic Breast Cancer. | NCT00448591 | Breast Cancer | bevacizumab [Av... Taxane-based ch... | 18 Years - | Hoffmann-La Roche | |
| A Study of Avastin (Bevacizumab) in Combination With Xeloda (Capecitabine) and Docetaxel in Patients With Inflammatory or Locally Advanced Breast Cancer. | NCT00576901 | Breast Cancer | bevacizumab [Av... Docetaxel Xeloda | 18 Years - | Hoffmann-La Roche | |
| A Study of Avastin (Bevacizumab) in Combination With XELOX in Patients With Metastatic Colorectal Cancer | NCT00700570 | Colorectal Canc... | bevacizumab [Av... capecitabine [X... oxaliplatin | - 75 Years | Hoffmann-La Roche | |
| A Study of Avastin (Bevacizumab) in Combination With Gemcitabine With or Without Cisplatin in First-Line Treatment of Elderly Patients With Non-Small Cell Lung Cancer | NCT01077713 | Non-Squamous No... | bevacizumab [Av... cisplatin gemcitabine gemcitabine | 70 Years - | Hoffmann-La Roche | |
| A Study of Avastin (Bevacizumab) in Combination With XELOX in Patients With Metastatic Colorectal Cancer | NCT00700570 | Colorectal Canc... | bevacizumab [Av... capecitabine [X... oxaliplatin | - 75 Years | Hoffmann-La Roche | |
| Observational Study of Bevacizumab [Avastin] in Patients With Metastatic Colorectal Cancer (AVASTART) | NCT01089413 | Colorectal Canc... | bevacizumab [Av... | 18 Years - | Hoffmann-La Roche |
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
